pharma · Alzheimer's Disease · Type 2 Diabetes Mellitus · VTVT
vTv Therapeutics
vTv Therapeutics trial registry — 14 ClinicalTrials.gov studies with program phase, status, and indication context.
3980 Premier Dr, Suite 110, High Point, North Carolina 27265, US HQ
55 Employees
Public company Type
VTVT · NYSE Ticker
Company details
- Status
- Public
- HQ
- 3980 Premier Dr, Suite 110, High Point, North Carolina 27265, US
- Employees
- 55
- Programs
- 14
- Drugs
- 2
- Patents
- 50
vTv Therapeutics clinical trials
Registry index of 14 ClinicalTrials.gov studies linked to vTv Therapeutics programs — each row shows trial ID, program name, phase, status, and indication.
vTv Therapeutics trial registry — 14 ClinicalTrials.gov studies with program phase, status, and indication context.
Recent trial activity
Latest clinical program signals indexed for vTv Therapeutics.
-
TTP889 — Phase 2
Clinical update -
TTP4000 — Phase 1
Clinical update -
Azeliragon — Phase 3
Clinical update -
Azeliragon — Phase 2
Clinical update -
Azeliragon 5mg — Phase 3
Clinical update -
Cadisegliatin 800 mg QD — Phase 3
Clinical update -
GK1-399 (formerly TTP399) — Phase 2
Clinical update -
TTP054 — Phase 2
Clinical update